News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
441,859 Results
Type
Article (24932)
Company Profile (152)
Press Release (416775)
Multimedia
Podcasts (43)
Webinars (11)
Section
Business (128344)
Career Advice (1011)
Deals (20821)
Drug Delivery (46)
Drug Development (48220)
Employer Resources (83)
FDA (11274)
Job Trends (9356)
News (211254)
Policy (17945)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (2)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (1908)
Accelerated approval (4)
Adcomms (3)
Allergies (50)
Alliances (38802)
ALS (42)
Alzheimer's disease (837)
Antibody-drug conjugate (ADC) (86)
Approvals (11310)
Artificial intelligence (257)
Autoimmune disease (12)
Automation (13)
Bankruptcy (153)
Best Places to Work (7999)
BIOSECURE Act (8)
Biosimilars (39)
Biotechnology (116)
Bladder cancer (38)
Brain cancer (15)
Breast cancer (182)
Cancer (1431)
Cardiovascular disease (85)
Career advice (843)
Career pathing (13)
CAR-T (117)
Cell therapy (311)
Cervical cancer (16)
Clinical research (37696)
Collaboration (693)
Compensation (146)
Complete response letters (4)
COVID-19 (1796)
CRISPR (38)
C-suite (166)
Cystic fibrosis (72)
Data (1443)
Decentralized trials (1)
Denatured (20)
Depression (17)
Diabetes (147)
Diagnostics (5212)
Digital health (17)
Diversity (5)
Diversity, equity & inclusion (17)
Drug discovery (93)
Drug pricing (34)
Drug shortages (7)
Duchenne muscular dystrophy (36)
Earnings (44739)
Editorial (15)
Employer branding (10)
Employer resources (72)
Events (62499)
Executive appointments (487)
FDA (12145)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (558)
Gene editing (98)
Generative AI (25)
Gene therapy (213)
GLP-1 (331)
Government (2598)
Grass and pollen (2)
Guidances (32)
Healthcare (12104)
Huntington's disease (9)
IgA nephropathy (15)
Immunology and inflammation (56)
Indications (21)
Infectious disease (1909)
Inflammatory bowel disease (85)
Inflation Reduction Act (4)
Influenza (48)
Intellectual property (70)
Interviews (142)
IPO (9164)
IRA (18)
Job creations (1719)
Job search strategy (737)
Kidney cancer (4)
Labor market (16)
Layoffs (176)
Leadership (8)
Legal (3306)
Liver cancer (48)
Lung cancer (180)
Lymphoma (88)
Machine learning (5)
Management (32)
Manufacturing (200)
MASH (25)
Medical device (11842)
Medtech (11847)
Mergers & acquisitions (12047)
Metabolic disorders (322)
Multiple sclerosis (42)
NASH (7)
Neurodegenerative disease (48)
Neuropsychiatric disorders (7)
Neuroscience (1113)
NextGen: Class of 2025 (4225)
Non-profit (2190)
Northern California (1524)
Now hiring (11)
Obesity (143)
Opinion (110)
Ovarian cancer (48)
Pain (60)
Pancreatic cancer (57)
Parkinson's disease (92)
Partnered (12)
Patents (168)
Patient recruitment (67)
Peanut (30)
People (37690)
Pharmaceutical (24)
Pharmacy benefit managers (5)
Phase I (14269)
Phase II (16333)
Phase III (11025)
Pipeline (763)
Policy (72)
Postmarket research (1072)
Preclinical (6582)
Press Release (67)
Prostate cancer (56)
Psychedelics (10)
Radiopharmaceuticals (186)
Rare diseases (221)
Real estate (3691)
Recruiting (33)
Regulatory (13353)
Reports (20)
Research institute (1794)
Resumes & cover letters (193)
Rett syndrome (3)
RNA editing (2)
RSV (28)
Schizophrenia (24)
Series A (98)
Series B (63)
Service/supplier (7)
Sickle cell disease (39)
Southern California (1481)
Special edition (2)
Spinal muscular atrophy (88)
Sponsored (20)
Startups (2812)
State (2)
Stomach cancer (4)
Supply chain (32)
Tariffs (8)
The Weekly (22)
United States (14645)
Vaccines (472)
Venture capitalists (21)
Weight loss (62)
Women's health (20)
Worklife (3)
Date
Today (57)
Last 7 days (465)
Last 30 days (1505)
Last 365 days (21523)
2025 (6485)
2024 (23320)
2023 (27108)
2022 (36746)
2021 (39120)
2020 (36638)
2019 (30708)
2018 (23348)
2017 (22295)
2016 (21169)
2015 (24727)
2014 (18544)
2013 (15530)
2012 (16525)
2011 (16912)
2010 (15246)
Location
Africa (474)
Alabama (43)
Alaska (6)
Arizona (139)
Arkansas (10)
Asia (28699)
Australia (5069)
California (3716)
Canada (1205)
China (330)
Colorado (186)
Connecticut (168)
Delaware (83)
Europe (59845)
Florida (595)
Georgia (150)
Hawaii (1)
Idaho (35)
Illinois (339)
India (16)
Indiana (204)
Iowa (5)
Japan (131)
Kansas (88)
Kentucky (10)
Louisiana (9)
Maine (21)
Maryland (686)
Massachusetts (2704)
Michigan (196)
Minnesota (278)
Mississippi (2)
Missouri (65)
Montana (26)
Nebraska (16)
Nevada (29)
New Hampshire (66)
New Jersey (1205)
New Mexico (22)
New York (1015)
North Carolina (647)
North Dakota (7)
Northern California (1524)
Ohio (120)
Oklahoma (11)
Oregon (21)
Pennsylvania (849)
Puerto Rico (9)
Rhode Island (27)
South America (652)
South Carolina (20)
South Dakota (1)
Southern California (1481)
Tennessee (67)
Texas (552)
Utah (113)
Virginia (86)
Washington D.C. (23)
Washington State (401)
West Virginia (3)
Wisconsin (39)
441,859 Results for "human metabolome technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Metabolon Expands Library to Include 70 Pesticides, Advancing Human Exposome Insights through Metabolomics
July 16, 2024
·
3 min read
Press Releases
Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology
February 27, 2025
·
5 min read
Press Releases
Metabolomics Market Size Expand $11.32 Bn at 13.43% CAGR by 2034
February 27, 2025
·
1 min read
Press Releases
Ecotone Achieves Breakthrough in Human Genome Understanding with Novel AI Technology
AI-Powered Genomic Mapping Could Revolutionize Treatment of Rare Genetic Diseases
January 16, 2025
·
1 min read
Press Releases
BioNxt Solutions Prepares for Human Bioequivalence Study For MS
April 23, 2025
·
3 min read
Press Releases
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
March 19, 2025
·
4 min read
Press Releases
Breakthrough technology for human muscle fatigue measure, Myocene, gets FDA “de novo” approval.
January 30, 2025
·
2 min read
Business
MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies
MAX BioPharma, Inc. and Metaba, LLC announced their collaboration in studying the effects of oxysterol drug candidates that target non-alcoholic steatohepatitis, idiopathic pulmonary fibrosis, chronic inflammation, and atherosclerosis on metabolic processes using Metaba’s state of the art metabolomics platform technology.
February 26, 2024
·
4 min read
Press Releases
Nona Biosciences Integrates Cutting-Edge AI Technology to Enhance Its Fully Human Antibody Platform, Accelerating Antibody Discovery Across Key Therapeutic Areas
March 7, 2025
·
3 min read
BioMidwest
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
Creative Medical Technology Holdings, Inc. announced that it has successfully generated human induced pluripotent stem cells -derived Islet Cells that produce human insulin.
June 24, 2024
·
3 min read
1 of 44,186
Next
